Clinical Trials Directory

Trials / Unknown

UnknownNCT04783493

Transcutaneous Magnetic Spinal Cord Stimulation for Freezing of Gait in Parkinson's Disease

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
38 (estimated)
Sponsor
University of Sao Paulo General Hospital · Academic / Other
Sex
All
Age
21 Years – 81 Years
Healthy volunteers
Not accepted

Summary

Dopaminergic drugs partially alleviate gait problems in Parkinson's disease, but the effects are not sustained in the long-term. Particularly, the freezing of gait, balance problems and other gait issues directly impacts patients' quality of life. Experimental epidural spinal cord stimulation studies have suggested positive effects on locomotion among PD patients, but the effects of non invasive stimulation have never been explored.

Detailed description

The present study is a randomized, double-blind, placebo-controlled, parallel, phase II clinical trial that will assess the efficacy and safety of transcutaneous magnetic spinal cord stimulation in PD patients who have gait and balance changes refractory to dopaminergic therapy.

Conditions

Interventions

TypeNameDescription
DEVICENon-invasive magnetic stimulation of the spinal cordNon-invasive transcutaneous magnetic stimulation of the dorsal spine will be applied by placing a circular magnetic coil (Magventure®️ MagPro®️ R20) on the skin, in the upper thoracic region (chest level T2-T3). The stimulation intensity will represent 100% of the motor threshold. The intermittent theta burst stimulation protocol will consist of 20 stimulation trains, with an interval of 8 seconds between trains, each train will have 20 bursts, and each burst will have 3 pulses at 50 Hz repeated at 5 Hz. In total, 1200 pulses will be applied for 3 minutes and 58 seconds
OTHERCoil will not be connected to the stimulation devicecoil will not be connected to the stimulation device, and another active coil will be positioned about 15cm behind, far from its field of view, to provide idea from the sound stimulus that is being stimulated

Timeline

Start date
2021-01-01
Primary completion
2021-09-29
Completion
2022-01-31
First posted
2021-03-05
Last updated
2021-04-02

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT04783493. Inclusion in this directory is not an endorsement.